顔写真

PHOTO

Eisuke Mekada
目加田 英輔
Eisuke Mekada
目加田 英輔
Institute for Transdisciplinary Graduate Degree Programs,Specially Appointed Professor

Research History 7

  1. 2024/04 - Present
    滋慶医療科学大学大学院 客員教授

  2. 2019/02/16 - Present
    Osaka University Institute for Transdisciplinary Graduate Degree Programs Specially Appointed Professor

  3. 2000/01/01 - 2017/03/31
    Osaka University Research Institute for Microbial Diseases Professor

  4. 2011/10 - 2015/10
    大阪大学・微生物病研究所・所長

  5. 1988/09 - 1999/12
    久留米大学教授

  6. 1988/04 - 1988/08
    大阪大学助教授

  7. 1979/11 - 1988/03
    大阪大学助手

Education 2

  1. Yamagata University Faculty of Science

    - 1974/03

  2. Yamagata University Faculty of Science

    - 1974

Committee Memberships 1

  1. Japan Society for Cell Biology President Academic society

    2012/04 - 2014/03

Professional Memberships 4

  1. Japan Society for Cell Biology

  2. Japanese Cancer Association

  3. 日本細菌学会

  4. 日本生化学会

Research Areas 4

  1. Life sciences / Bacteriology /

  2. Life sciences / Cell biology /

  3. Life sciences / Molecular biology /

  4. Life sciences / Functional biochemistry /

Papers 134

  1. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation.

    Lei Zhou, Wenqing Zhou, Ann M Joseph, Coco Chu, Gregory G Putzel, Beibei Fang, Fei Teng, Mengze Lyu, Hiroshi Yano, Katrin I Andreasson, Eisuke Mekada, Gerard Eberl, Gregory F Sonnenberg

    Nature immunology Vol. 23 No. 2 p. 251-261 2022/02 Research paper (scientific journal)

  2. Spread of genetically similar noroviruses in Bangkok, Thailand, through symptomatic and asymptomatic individuals

    Patcharaporn Boonyos, Michittra Boonchan, Benjarat Phattanawiboon, Nutthawan Nonthabenjawan, Ratana Tacharoenmuang, Ratigorn Gunpapong, Phakapun Singchai, Sompong Upchai, Pimpha Rungnobhakhun, Jutarat Mekmullica, Worakarn Towayunanta, Kobkool Chuntrakool, Karn Ngaopravet, Kriangsak Ruchusatsawat, Somchai Sangkitporn, Ballang Uppapong, Eisuke Mekada, Yoshiharu Matsuura, Masashi Tatsumi, Hiroto Mizushima

    Heliyon Vol. 7 No. 10 p. e08250-e08250 2021/10 Research paper (scientific journal)

    Publisher: Elsevier BV
  3. Identification of GII.14[P7] norovirus and its genomic mutations from a case of long-term infection in a post-symptomatic individual.

    Nutthawan Nonthabenjawan, Patcharaporn Boonyos, Benjarat Phattanawiboon, Worakarn Towayunanta, Kobkool Chuntrakool, Karn Ngaopravet, Kriangsak Ruchusatsawat, Ballang Uppapong, Somchai Sangkitporn, Eisuke Mekada, Yoshiharu Matsuura, Masashi Tatsumi, Hiroto Mizushima

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases Vol. 86 p. 104612-104612 2020/12 Research paper (scientific journal)

  4. Norovirus transmission mediated by asymptomatic family members in households.

    Benjarat Phattanawiboon, Nutthawan Nonthabenjawan, Patcharaporn Boonyos, Chanya Jetsukontorn, Worakarn Towayunanta, Kobkool Chuntrakool, Karn Ngaopravet, Kriangsak Ruchusatsawat, Ballang Uppapong, Somchai Sangkitporn, Eisuke Mekada, Yoshiharu Matsuura, Masashi Tatsumi, Hiroto Mizushima

    PloS one Vol. 15 No. 7 2020 Research paper (scientific journal)

  5. The use of green fluorescent protein-tagged virus-like particles as a tracer in the early phase of chikungunya infection.

    Tumkosit U, Maeda Y, Kishishita N, Siripanyaphinyo U, Omori H, Chetanachan P, Sittisaman P, Jityam C, Priengprom T, Mizushima H, Wongjaroen P, Mekada E, Tatsumi M, Takeda N, Tanaka A

    Virus research Vol. 272 2019/10 Research paper (scientific journal)

  6. Isolation of intragenic suppressor of tsp-15-splicing mutant in Caenorhabditis elegans.

    Hiroki Moribe, Eisuke Mekada

    microPublication biology Vol. 2019 2019/07/23 Research paper (scientific journal)

  7. Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice.

    Shota Tsuchida, Takashi Matsuzaki, Masaki Yamato, Keiji Okuda, Hai Ying Fu, Ryo Araki, Shoji Sanada, Hiroshi Asanuma, Yoshihiro Asano, Masanori Asakura, Hiroyuki Hao, Seiji Takashima, Masafumi Kitakaze, Yasushi Sakata, Eisuke Mekada, Tetsuo Minamino

    International heart journal Vol. 59 No. 6 p. 1425-1431 2018/11/28 Research paper (scientific journal)

  8. Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.

    Yingji Jin, Yoshito Takeda, Yasushi Kondo, Lokesh P Tripathi, Sujin Kang, Hikari Takeshita, Hanako Kuhara, Yohei Maeda, Masayoshi Higashiguchi, Kotaro Miyake, Osamu Morimura, Taro Koba, Yoshitomo Hayama, Shohei Koyama, Kaori Nakanishi, Takeo Iwasaki, Satoshi Tetsumoto, Kazuyuki Tsujino, Muneyoshi Kuroyama, Kota Iwahori, Haruhiko Hirata, Takayuki Takimoto, Mayumi Suzuki, Izumi Nagatomo, Ken Sugimoto, Yuta Fujii, Hiroshi Kida, Kenji Mizuguchi, Mari Ito, Takashi Kijima, Hiromi Rakugi, Eisuke Mekada, Isao Tachibana, Atsushi Kumanogoh

    Scientific reports Vol. 8 No. 1 p. 5145-5145 2018/03 Research paper (scientific journal)

  9. RNA Aptamer Binds Heparin-Binding Epidermal Growth Factor-Like Growth Factor with High Affinity and Specificity and Neutralizes Its Activity

    Masaki Yamato, Takashi Matsuzaki, Ryo Araki, Shota Tsuchida, Keiji Okuda, Hai Ying Fu, Shoji Sanada, Hiroshi Asanuma, Yoshihiro Asano, Masanori Asakura, Hiroomi Torii, Kentaro Noi, Hirotsugu Ogi, Ryo Iwamoto, Eisuke Mekada, Seiji Takashima, Masafumi Kitakaze, Yasushi Sakata, Tetsuo Minamino

    INTERNATIONAL JOURNAL OF GERONTOLOGY Vol. 11 No. 3 p. 191-196 2017/09 Research paper (scientific journal)

  10. ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis

    Ryo Iwamoto, Naoki Mine, Hiroto Mizushima, Eisuke Mekada

    JOURNAL OF CELL SCIENCE Vol. 130 No. 7 p. 1321-1332 2017/04 Research paper (scientific journal)

  11. Reconstitution of a metastatic-resistant tumor microenvironment with cancer-associated fibroblasts enables metastasis

    Takuya Murata, Eisuke Mekada, Robert M. Hoffman

    CELL CYCLE Vol. 16 No. 6 p. 533-535 2017/03 Research paper (scientific journal)

  12. Mathematical Modeling for Break Down of Dynamical Equilibrium in Bone Metabolism

    Takashi Suzuki, Keiko Itano, Rong Zou, Ryo Iwamoto, Eisuke Mekada

    ROLE AND IMPORTANCE OF MATHEMATICS IN INNOVATION Vol. 25 p. 25-34 2017 Research paper (international conference proceedings)

  13. BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

    Shingo Miyamoto, Fusanori Yotsumoto, Taeko Ueda, Tatsuya Fukami, Ayako Sanui, Kohei Miyata, Sung Ouk Nam, Satoshi Fukagawa, Takahiro Katsuta, Miyako Maehara, Haruhiko Kondo, Daisuke Miyahara, Kyoko Shirota, Toshiyuki Yoshizato, Masahide Kuroki, Hiroaki Nishikawa, Keijiro Saku, Yoshio Tsuboi, Kenji Ishitsuka, Yasushi Takamatsu, Kazuo Tamura, Akira Matsunaga, Toru Hachisuga, Shinsuke Nishino, Takashi Odawara, Kazuhiro Maeda, Sadao Manabe, Toyokazu Ishikawa, Yoshinobu Okuno, Minako Ohishi, Tomoya Hikita, Hiroto Mizushima, Ryo Iwamoto, Eisuke Mekada

    BMC CANCER Vol. 17 No. 1 2017/01 Research paper (scientific journal)

  14. SHP-2はFAKと協調的にHB-EGF依存的細胞増殖を亢進する

    水島寛人, 鈴木翔大, 目加田英輔

    2016/06

  15. マウス心臓弁形成過程におけるHB-EGF-ErbBシグナルによる細胞増殖制御

    岩本亮, 目加田英輔

    2016/06 Research paper (other academic)

  16. Characterization of a Novel Anti-Human HB-EGF Monoclonal Antibody Applicable for Paraffin-Embedded Tissues and Diagnosis of HB-EGF-Related Cancers

    Ryo Iwamoto, Mika Takagi, Jun-Ichi Akatsuka, Ken-Ichiro Ono, Yoshiro Kishi, Eisuke Mekada

    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Vol. 35 No. 2 p. 73-82 2016/04 Research paper (scientific journal)

    Publisher: Mary Ann Liebert Inc.
  17. HB-EGF依存的細胞増殖はFAKのリン酸化により制御される

    水島寛人, 船越敍希, 目加田英輔

    2015/06

  18. Physiological functions of diphtheria toxin receptor/HB-EGF

    Ryo Iwamoto, Eisuke Mekada

    2015/06 Research paper (international conference proceedings)

  19. Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF

    Keisuke Suzuki, Hiroto Mizushima, Hiroyuki Abe, Ryo Iwamoto, Haruki Nakamura, Eisuke Mekada

    JOURNAL OF BIOCHEMISTRY Vol. 157 No. 5 p. 331-343 2015/05 Research paper (scientific journal)

  20. ジフテリア毒素リセプターの同定から始まった細胞増殖因子研究

    目加田 英輔

    2015/01

  21. HB-EGFを標的とする抗癌剤の開発

    目加田 英輔

    2014/11

  22. Pre-clinical Study of BK-UM, a Novel Inhibitor of HB-EGF, for Ovarian Cancer Therapy

    Sung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, Yuki Suzaki, Hiroshi Yagi, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Masahide Kuroki, Eisuke Mekada, Shingo Miyamoto

    ANTICANCER RESEARCH Vol. 34 No. 8 p. 4615-4620 2014/08 Research paper (scientific journal)

  23. Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF

    Ayaka Okamoto, Tomohiro Asai, Hiroki Kato, Hidenori Ando, Tetsuo Minamino, Eisuke Mekada, Naoto Oku

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 449 No. 4 p. 460-465 2014/07 Research paper (scientific journal)

  24. FAKリン酸化によるHB-EGF依存的細胞増殖制御

    水島寛人, 船越敍希, 目加田英輔

    2014/06

  25. 破骨細胞分化過程におけるHB-EGF細胞質内領域の機能

    中村尚志, 岩本亮, 目加田英輔

    2014/06

  26. 心臓弁形成におけるHB-EGF-ErbBシグナルによる細胞増殖制御

    岩本亮, 目加田英輔

    2014/06 Research paper (other academic)

  27. Co-occurrence of tetraspanin and ROS generators: Conservation in protein cross-linking and other developmental processes.

    Moribe H, Mekada E

    Worm. Vol. 2 No. 2 2013/09 Research paper (scientific journal)

  28. Metastasis Suppressor Tetraspanin CD82/KAI1 Regulates Ubiquitylation of Epidermal Growth Factor Receptor.

    Odintsova E, van Niel G, Conjeaud H, Raposo G, Iwamoto R, Mekada E, Berditchevski F

    JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 288 No. 36 p. 26323-26334 2013/07 Research paper (scientific journal)

  29. 微小菅によるFAKの隔離はHB-EGF依存的細胞増殖を負に制御する

    水島寛人, 船越敍希, 目加田英輔

    2013/06

  30. 卵巣癌におけるマイコプラズマ感染の関与

    疋田智也, 清水隆, 桑野剛一, 宮本新伍, 目加田英輔

    2013/06

  31. 増殖因子HB-EGF細胞質内領域による破骨細胞分化制御機構の解明

    中村尚志, 佐藤みずほ, 岩本亮, 目加田英輔

    2013/06

  32. 卵巣癌におけるマイコプラズマ感染の関与

    疋田智也, 清水隆, 桑野剛一, 宮本新伍, 目加田英輔

    2013/05

  33. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.

    Takemura T, Yoshida Y, Kiso S, Kizu T, Furuta K, Ezaki H, Hamano M, Egawa M, Chatani N, Kamada Y, Imai Y, Higashiyama S, Iwamoto R, Mekada E, Takehara T

    Biochem Biophys Res Commun. Vol. 437 No. 2 p. 185-191 2013/05 Research paper (scientific journal)

  34. Conditional Knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice.

    Takemura, T, Yoshida, Y, Kiso, S, Saji, Y, Ezaki, H, Hamano, M, Kizu, T, Egawa, M, Chatani, N, Furuta, K, Kamada, Y, Iwamoto, R, Mekada, E, Higashiyama, S, Hayashi, N, Takehara, T

    Hepatol Res. Vol. 43 No. 4 p. 384-393 2013/04 Research paper (scientific journal)

  35. Tetraspanins in lower eukaryotes

    Hiroki Moribe, Eisuke Mekada

    Tetraspanins p. 187-201 2013/01/01 Part of collection (book)

    Publisher: Springer Netherlands
  36. Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer

    Noriyuki Kasai, Kazuhiro Kobayashi, Shinobu Shioya, Yukitaka Yoshikawa, Fusanori Yotsumoto, Shingo Miyamoto, Eisuke Mekada, Junichi Enokizono

    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH Vol. 4 No. 4 p. 415-421 2012/10 Research paper (scientific journal)

  37. Tetraspanin Is Required for Generation of Reactive Oxygen Species by the Dual Oxidase System in Caenorhabditis elegans.

    Moribe, H, Konakawa, R, Koga, D, Ushiki, T, Nakamura, K, Mekada, E

    PLoS Genet. Vol. 8 No. 9 2012/09 Research paper (scientific journal)

  38. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers

    Takuya Murata, Takayuki Enomoto, Yutaka Ueda, Kiyoshi Yoshino, Shigeo Yagi, Robert M. Hoffman, Hiroto Mizushima, Tadashi Kimura, Eisuke Mekada

    CANCER RESEARCH Vol. 72 2012/04

  39. HB-EGF (Heparin-Binding EGF-Like Growth Factor)

    Iwamoto, R, Mekada, E

    Encyclopedia of Signalling Molecules 2012

  40. MIG-13 controls anteroposterior cell migration by interacting with UNC-71/ADM-1 and SRC-1 in Caenorhabditis elegans.

    Masuda, H, Nakamura, K, Takata, N, Itoh, B, Hirose, T, Moribe, H, Mekada, E, Okada, M

    FEBS Lett. Vol. 586 No. 6 p. 740-746 2012/01 Research paper (scientific journal)

  41. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.

    Murata, T, Mizushima, H, Chinen, I, Moribe, H, Yagi, S, Hoffman, R.M, Kimura, T, Yoshino, K, Ueda, Y, Enomoto, T, Mekada, E

    Cancer Res. Vol. 71 No. 21 p. 6633-6642 2011/10 Research paper (scientific journal)

  42. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.

    Nishikawa, K, Asai, T, Shigematsu, H, Shimizu, K, Kato, H, Asano, Y, Takashima, S, Mekada, E, Oku, N, Minamino, T

    J Control Release. Vol. 160 No. 2 p. 274-280 2011/10 Research paper (scientific journal)

  43. 子宮頸癌では、HB-EGFとPDGFを介して癌細胞と癌関連線維芽細胞が相互作用し、癌細胞の増殖を促進する(HB-EGF and PDGF Contribute to the Reciprocal Interaction of Cancer Epithelial Cells with CAF in Uterine Cervical Cancers)

    村田 卓也, 水島 寛人, 吉野 潔, 上田 豊, 榎本 隆之, 木村 正, 目加田 英輔

    日本癌学会総会記事 Vol. 70回 p. 106-106 2011/09

    Publisher: (一社)日本癌学会
  44. A novel anti-human HB-EGF monoclonal antibody with multiple anti-tumor mechanisms against ovarian cancer cells.

    Miyamoto, S, Iwamoto, R, Furuya, A, Takahashi, K, Sasaki, Y, Ando, H, Yotsumoto, F, Yoneda, T, Hamaoka, M, Yagi, H, Murakami, T, Hori, S, Shitara, K, Mekada, E

    Clinical Cancer Res. Vol. 17 No. 21 p. 6733-6741 2011/09 Research paper (scientific journal)

  45. Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA.

    Hikita S, Yotsumoto F, Fumaki T, Horiuchi S, Sanui A, Miyata K, Nam SO, Tsujioka H, Ueda T, Shirota K, Yoshizato T, Maeda K, Ishikawa T, Okuno Y, Kuroki M, Mekada E, Miyamoto S

    Anticancer Res. Vol. 31 No. 7 p. 2553-2559 2011/07 Research paper (scientific journal)

  46. Role of ectodomain shedding in physiological functions of HB-EGF.

    2010/12 Research paper (other academic)

  47. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.

    Koshikawa N, Mizushima H, Minegishi T, Eguchi F, Yotsumoto F, Nabeshima K, Miyamoto S, Mekada E, Seiki M

    Cancer Sci. Vol. 102 No. 1 p. 111-116 2010/10 Research paper (scientific journal)

  48. HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans.

    Iwamoto, R, Mine, N, Kawaguchi, T, Minami, S, Saeki, K, Mekada, E

    Development. Vol. 137 No. 13 p. 2205-2214 2010/07 Research paper (scientific journal)

  49. Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH2-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor

    Naohiko Koshikawa, Hiroto Mizushima, Tomoko Minegishi, Ryo Iwamoto, Eisuke Mekada, Motoharu Seiki

    CANCER RESEARCH Vol. 70 No. 14 p. 6093-6103 2010/07 Research paper (scientific journal)

  50. MT1-MMP cleaves off the NH2-terminal portion of HB-EGF and converts it into a heparin-independent growth factor.

    Koshikawa, N, Mizushima, H, Minegishi, T, Iwamoto, R, Mekada, E, Seiki, M

    Cancer Res. 2010/06 Research paper (scientific journal)

  51. 心臓弁形成におけるヘパラン硫酸プロテオグリカンによるHB-EGFの機能制御.

    岩本亮, 目加田英輔

    2010/05 Research paper (other academic)

  52. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding.

    Hamaoka, M, Chinen, I, Murata, T, Takashima, S, Iwamoto, R, Mekada, E

    J. Biochem. Vol. 148 No. 1 p. 55-69 2010/03 Research paper (scientific journal)

  53. Humanized Gene Replacement in Mice Reveals the Contribution of Cancer Stroma-Derived HB-EGF to Tumor Growth.

    Ichise T, Adachi S, Ohishi M, Ikawa M, Okabe M, Iwamoto R, Mekada E

    Cell Struct Funct. Vol. 35 No. 1 p. 3-13 2010/01 Research paper (scientific journal)

  54. HB-EGFとヘパラン硫酸プロテオグリカンの相互作用は正常な心臓弁形成に必須である.

    岩本亮, 目加田英輔

    2009/06 Research paper (other academic)

  55. HB-EGF and amphiregulin are promising targets for human cancer therapy (in Japanese)

    Yotsumoto F, Yagi H, Suzuki S, Oki E, Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Kuroki M, Mekada E, Miyamoto S

    Mol Tumor Marker Res Vol. 24 No. 1 p. 73-75 2009 Research paper (scientific journal)

    Publisher: Japanese Society for Molecular Tumor Marker Research
  56. Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.

    Miyamoto S, Yagi H, Yotsumoto F, Kawarabayashi T, Mekada E

    Adv Exp Med Biol. Vol. 622 p. 281-295 2008/09 Research paper (scientific journal)

  57. HB-EGFはTGFaと協調しEGFRを介して、胎盤迷宮層の血管形成に寄与している.

    南誠剛, 岩本亮, 目加田英輔

    2008/07

  58. HB-EGFの生理機能発揮におけるエクトドメイン・シェディングの役割.

    岩本亮, 目加田英輔

    2008/06

  59. Phase I study of BK-UK (CRM197) in patients with ovarian cancer

    Miyamoto S, Yotsumoto F, Fukami T, Sanui A, Kuroki M, Mekada E

    Tumor Biol Vol. 29 No. S1 p. 23-25 2008 Research paper (scientific journal)

  60. Efficacy of cross-reacting material 197 (CRM197), a specific inhibitor for heparin-binding epidermal growth factor-like growth factor (HB), in breast cancer patients

    Yotsumoto F, Oki E, Tokunaga E, Maehara Y, Kuroki M, Mizushima H, Mekada E, Miyamoto S

    Tumor Biol Vol. 29 No. S1 p. 32-34 2008 Research paper (scientific journal)

  61. The inhibition of amphireguilin blocks AKT as well as ERK activations in pancreatic cancer

    Fukami T, Yagi H, Yotsumoto F, Funakoshi A, Kuroki M, Mekada E, Miyamoto S

    Tumor Biol Vol. 29 No. S1 p. 35-37 2008 Research paper (scientific journal)

  62. New approach to cancer therapy: Heparin binding-epidermal growth factor-like growth factor as a novel, targeting molecule

    Shingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, Shinji Horiuchi, Toshiyuki Yoshizato, Tatsuhiko Kawarabayashi, Masahide Kuroki, Eisuke Mekada

    ANTICANCER RESEARCH Vol. 27 No. 6A p. 3713-3721 2007/11 Research paper (scientific journal)

  63. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy

    S Miyamoto, H Yagi, F Yotsumoto, T Kawarabayashi, E Mekada

    CANCER SCIENCE Vol. 97 No. 5 p. 341-347 2006/05

  64. Toxin receptors

    Yasuhiko Horiguchi, Eisuke Mekada

    The Comprehensive Sourcebook of Bacterial Protein Toxins p. 106-119 2006 Part of collection (book)

    Publisher: Elsevier Inc.
  65. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer

    Y Tanaka, S Miyamoto, SO Suzuki, E Oki, H Yagi, K Sonoda, A Yamazaki, H Mizushima, Y Maehara, E Mekada, H Nakano

    CLINICAL CANCER RESEARCH Vol. 11 No. 13 p. 4783-4792 2005/07 Research paper (scientific journal)

  66. Tetraspanin protein (TSP-15) integrity is required for epidermal integrity in Caenorhabditis elegans

    H Moribe, J Yochem, H Yamada, Y Tabuse, T Fujimoto, E Mekada

    JOURNAL OF CELL SCIENCE Vol. 117 No. 22 p. 5209-5220 2004/10 Research paper (scientific journal)

  67. [Biological behavior of ovarian cancer].

    Miyamoto S, Mekada E

    Nihon rinsho. Japanese journal of clinical medicine Vol. 62 Suppl 10 p. 458-462 2004/10

  68. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy

    S Miyamoto, M Hirata, A Yamazaki, T Kageyama, H Hasuwa, H Mizushima, Y Tanaka, H Yagi, K Sonoda, M Kai, H Kanoh, H Nakano, E Mekada

    CANCER RESEARCH Vol. 64 No. 16 p. 5720-5727 2004/08 Research paper (scientific journal)

  69. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades

    H Takenobu, A Yamazaki, M Hirata, T Umata, E Mekada

    JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278 No. 19 p. 17255-17262 2003/05 Research paper (scientific journal)

  70. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer

    T Fujita, S Miyamoto, Onoyama, I, K Sonoda, E Mekada, H Nakano

    CANCER LETTERS Vol. 192 No. 2 p. 161-169 2003/03 Research paper (scientific journal)

  71. HB-EGF and ErbB signaling is essential for heart function.

    Iwamoto, R, Yamazaki, S, Asakura, M, Takashima, S, Hasuwa, H, Miyado, K, Adachi. S, Kitakaze, M, Hashimoto, K, Raab, G, Nanba, D, Higashiyama, S, Hori, M, Klagsbrun, M, Mekada, E

    Proc. Natl. Acad. Sci. U.S.A., 100, 3221-3226. 2003/01 Research paper (scientific journal)

  72. A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor

    Toshiyuki Umata, Michinari Hirata, Tsuyoshi Takahashi, Fuminori Ryu, Seiichirou Shida, Yoshie Takahashi, Makoto Tsuneoka, Yoshiki Miura, Minako Masuda, Yasuhiko Horiguchi, Eisuke Mekada

    Journal of Biological Chemistry Vol. 276 No. 32 p. 30475-30482 2001/08/10 Research paper (scientific journal)

  73. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers.

    Miyamoto, S, Maruyama, A, Okugawa, K, Akazawa, K, Baba, H, Maehara, Y, Mekada, E

    Cancer Vol. 92 No. 3 p. 542-548 2001/08 Research paper (scientific journal)

  74. Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras.

    MEKADA Eisuke

    Oncogene Vol. 19 No. 1 p. 115-123 2000/04 Research paper (scientific journal)

    Publisher: Nature Publishing Group
  75. Enhanced CD9 expression in the human and mouse brains infected with transmissible spongiform encephalopathies.

    MEKADA Eisuke

    J. Neuropathol. Exp. Neurol. Vol. 59 No. 9 p. 774-785 2000/04 Research paper (scientific journal)

    Publisher: American Association of Neuropathologists Inc.
  76. Integrin-dependent EGF Receptor Activation at cell-Contact Sites.

    MEKADA Eisuke

    J. Cell Sci. Vol. 113 No. 12 p. 2139-2147 2000/04 Research paper (scientific journal)

  77. Importance of the Major Extracellular Domain of CD9 and the EGF-like Domain of HB-EGF for Upregulation of Binding and Activity.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 275 No. 24 p. 18284-18290 2000/04 Research paper (scientific journal)

  78. Identification of mammalian Tom22 as a subunit of the preprotein translocase of the mitochondrial outer membrane.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 275 No. 41 p. 31996-32002 2000/04 Research paper (scientific journal)

  79. Characterization of Rat Tom40, a central component of the preprotein yranslocase of the mitochondrial outer membrane.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 275 No. 48 p. 37930-37936 2000/04 Research paper (scientific journal)

  80. リゾフォスファチジン酸によるDTR/HB-EGFの細胞外領域の切断

    馬田敏幸, 高橋剛, 堀口安彦, 目加田英輔

    2000/03

  81. Requirement of CD9 on the Egg Plasma Membrane for Fertilization

    Kenji Miyado, Gen Yamada, Shuichi Yamada, Hidetoshi Hasuwa, Yasuhiro Nakamura, Fuminori Ryu, Kentaro Suzuki, Kenichiro Kosai, Kimiko Inoue, Atsuo Ogura, Masaru Okabe, Eisuke Mekada

    Science Vol. 287 No. 5451 p. 321-324 2000/01 Research paper (scientific journal)

    Publisher: The American Association for the Advancement of Science
  82. リゾフォスファチジン酸はHB-EGFのectodomain sheddingを誘発する

    馬田敏幸, 平田道也, 志田誠一郎, 劉文憲, 高橋よしえ, 堀口安彦, 常岡誠, 目加田英輔

    1999/12

  83. エンドサイトーシスとシグナル伝達

    岩本 亮, 目加田 英輔

    シュプリンガー・フェアラーク社 細胞内物質輸送のダイナミズム 1999/09

    Publisher: シュプリンガー・フェアラーク社
  84. Contact-dependent Growth Inhibition and Apoptosis of EGF Receptor-expressing Cells by the Membrane-anchored Form of Heparin-binding EGF-like Growth Factor.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 274 p. 25906-25912 1999/04 Research paper (scientific journal)

  85. 細胞増殖因子の機能と細胞外マトリックスおよび細胞接着因子

    岩本 亮, 目加田 英輔

    医学&サイエンスシリーズ 細胞接着のしくみと疾患 1998/06

    Publisher: 羊土社
  86. N-myc transactivates RCC1 gene expression in rat fibroblast cells transformed by N-myc and v-ras.

    MEKADA Eisuke

    J. Biolchem. Vol. 124 No. 5 p. 1013-1019 1998/04 Research paper (scientific journal)

  87. Diphtheria toxin translocation across endosome membrane. A novel cell premeabilization assay reveals new diphtheria toxin fragments in endocytic vesicles.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 273 No. 14 p. 8351-8359 1998/04 Research paper (scientific journal)

  88. A metalloprotease-disintegrin, MDC9/Meltrin-_/ADMA9, and PKC_are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

    MEKADA Eisuke

    EMBO J. Vol. 17 No. 24 p. 7260-7272 1998/04 Research paper (scientific journal)

  89. Immune system-related CD9 is expressed in mouse CNS myelin at very late stage of myelination.

    MEKADA Eisuke

    J. Neurosci. Res. Vol. 50 No. 2 p. 312-320 1997/04 Research paper (scientific journal)

  90. c-myc activates RCC1 gene expression through E-box elements.

    MEKADA Eisuke

    Oncogene Vol. 14 No. 19 p. 2301-2311 1997/04 Research paper (scientific journal)

  91. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 272 No. 43 p. 27084-27090 1997/04 Research paper (scientific journal)

  92. 膜結合型増殖因子によるジャクスタクライン機構

    岩本 亮, 目加田 英輔

    実験医学 増刊 細胞接着研究の最前線 1996/10

    Publisher: 羊土社
  93. Diphtheria Toxin Receptor Complex

    MEKADA Eisuke, SHISHIDO Yuji, KAILASH D.sharma

    Zeitschrift der Japanischen Mikrobiologische Gesellschaft Vol. 51 No. 3 p. 853-862 1996/07/25

    Publisher: JAPANESE SOCIETY FOR BACTERIOLOGY
  94. Expression and distribition of CD9 in myelin of the central and peripheral nervous systems.

    MEKADA Eisuke

    Am. J. Pathol. Vol. 149 No. 2 p. 575-583 1996/04 Research paper (scientific journal)

  95. Amino-terminal processing of cell surface haparin-binding EGF-like growth factor upregulates its juxtacrine but not its paracrine growth factor activity.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 271 No. 48 p. 30858-30863 1996/04 Research paper (scientific journal)

  96. ジフテリア毒素

    岩本 亮, 目加田 英輔

    実験医学 増刊 GTP結合蛋白質 1996/01

    Publisher: 羊土社
  97. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27/CD9) form a complex with Integrin α3β1 at cell-cell contact sites

    Nakamura, K, Iwamoto, R, Mekada, E

    J. Cell Biol. Vol. 129 p. 1691-1705 1995/06 Research paper (scientific journal)

  98. Membrane anchored heparin-binding EGF-like growth factor and DRAP27/CD9 form a complex with integrin a3bl at cell-cell contact sites.

    MEKADA Eisuke

    J. Cell Biol. 1995/04 Research paper (scientific journal)

  99. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding EGF-like growth factor.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 270 No. 49 p. 29578-29585 1995/04 Research paper (scientific journal)

  100. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor ; Conversion from juxtacrine to paracrine growth factor activity.

    MEKADA Eisuke

    Mol. Biol. Cell Vol. 6 No. 8 p. 967-980 1995/04 Research paper (scientific journal)

  101. The membrane protein CD9/DRAP27 potentiates the growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor(HB-EGF).

    MEKADA Eisuke

    J. Cell Biol. Vol. 128 No. 5 p. 929-938 1995/04 Research paper (scientific journal)

  102. Diphtheria toxin binds to the EGF-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 270 No. 3 p. 1015-1019 1995/04 Research paper (scientific journal)

  103. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity.

    MEKADA Eisuke

    EMBO J. Vol. 13 No. 10 p. 2322-2330 1994/04 Research paper (scientific journal)

  104. COEXPRESSION OF DIPHTHERIA-TOXIN RECEPTOR AND DRAP27 IN MOUSE L-CELLS - DRAP27 ELEVATES THE NUMBER OF DIPHTHERIA-TOXIN RECEPTORS ON THE CELL-SURFACE BUT NOT CHANGES THE BINDING-AFFINITY FOR THE TOXIN

    R IWAMOTO, S HIGASHIYAMA, T MITAMURA, JA ABRAHAM, M KLAGSBRUN, E MEKADA

    BACTERIAL PROTEIN TOXINS Vol. 24 p. 519-520 1994 Research paper (international conference proceedings)

  105. CLONING OF THE DIPHTHERIA-TOXIN RECEPTOR-ASSOCIATED PROTEIN (DRAP27) - DRAP27, MONKEY HOMOLOG OF HUMAN CD9 ANTIGEN, SERVES TO ENHANCE TOXIN SENSITIVITY

    E MEKADA, T MITAMURA, R IWAMOTO, T UMATA, T YOMO, URABE, I, M TSUNEOKA

    BACTERIAL PROTEIN TOXINS Vol. 24 p. 521-522 1994 Research paper (international conference proceedings)

  106. Analysis of Lewis fucosyltransferase genes from the human gastric mucosa of Lewis-positive and -negative individuals.

    MEKADA Eisuke

    Blood Vol. 82 No. 9 p. 2915-2919 1993/04 Research paper (scientific journal)

  107. Evidence for involvement of furin in cleavage and activation of diphtheria toxin.

    MEKADA Eisuke

    J. Biol. Chem Vol. 268 No. 35 p. 26461-26465 1993/04 Research paper (scientific journal)

  108. Diphtheria toxin receptor.

    MEKADA Eisuke

    Zeitschrift der Japanischen Mikrobiologische Gesellschaft Vol. 48 No. 5 p. 685-692 1993

    Publisher: JAPANESE SOCIETY FOR BACTERIOLOGY
  109. A27-KDA MEMBRANE-PROTEIN ASSOCIATES WITH THE DIPHTHERIA-TOXIN RECEPTOR

    E MEKADA, R IWAMOTO, H SENOH, Y OKADA, T UCHIDA

    BACTERIAL PROTEIN TOXINS Vol. 23 p. 333-340 1993 Research paper (international conference proceedings)

  110. Degradation of a nuclear-localized protein in mammalian COS cells using Escerichia coli beta-galactosidase as a model protein.

    MEKADA Eisuke

    J. Biol. Chem Vol. 267 No. 13 p. 9107-9111 1992/04 Research paper (scientific journal)

  111. The 27-kD diphtheria toxin receptor-associated protein(DRAP27)form Vero cells is the monkey homologue of human CD9 antigen : Expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells.

    MEKADA Eisuke

    J. Cell Biol. Vol. 118 No. 6 p. 1389-1399 1992/04 Research paper (scientific journal)

  112. An antibody that inhibits the binding of diphtheria toxin to cells, revealed the association of a 27-kDa membrane protein with the dephtheria toxin receptor.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 266 No. 30 p. 20463-20469 1991/04 Research paper (scientific journal)

  113. Purification of diphtheria toxin receptor from Vero cells.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 266 No. 30 p. 20457-20462 1991/04 Research paper (scientific journal)

  114. The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin Al, a specific inhibitor of vacuolar-type H┣D1+┫D1-ATPase.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 265 No. 35 p. 21940-21945 1990/04 Research paper (scientific journal)

  115. A monoclonal antibody to diphtheria toxin receptor

    R. Iwamoto, H. Senoh, T. Umata, Y. Okada, T. Uchida, E. Mekada

    Japanese Journal of Medical Science and Biology Vol. 42 No. 5-6 p. 212-213 1989 Research paper (international conference proceedings)

  116. Identification of diphtheria toxin receptor and a non-proteinous diphtheria toxin-binding molecule in Vero cell membrane.

    MEKADA Eisuke

    J. Cell Biol. Vol. 107 No. 2 p. 511-519 1988/04 Research paper (scientific journal)

  117. A mutant cell has diphtheria toxin receptor and acidification function but is defective in entry of the toxin into cell.

    MEKADA Eisuke

    Exptl. Cell Res. Vol. 172 No. 1 p. 54-64 1987/04 Research paper (scientific journal)

  118. Binding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain.

    MEKADA Eisuke

    J. Biol. Celm. Vol. 260 No. 22 p. 2148-2153 1985/04 Research paper (scientific journal)

  119. Characterization of diphtheria toxin-resistant mutants lacking receptor function or containing nonribosylatable elongation factor2.

    MEKADA Eisuke

    Somat. Cell Genet. Vol. 11 No. 5 p. 421-431 1985/04 Research paper (scientific journal)

  120. Monoclonal antibodies against diphtheria toxin fragment A.

    MEKADA Eisuke

    Exptl. Cell Res. 1984/04 Research paper (scientific journal)

  121. Entry of diphtheria toxin into celles : Possible existence of cellular factor(s) for entry of diphtheria toxin into cells was studied in somatic cell hybrids and hybrid toxins.

    MEKADA Eisuke

    J. Cell Biol. Vol. 98 No. 2 p. 466-472 1984/04 Research paper (scientific journal)

  122. MONOCLONAL-ANTIBODIES AGAINST DIPHTHERIA-TOXIN FRAGMENT-A - CHARACTERIZATION AND INTRODUCTION INTO LIVING CELLS

    T YOSHIMORI, M YAMADA, H SUGAWA, E MEKADA, T UCHIDA, Y OKADA

    EXPERIMENTAL CELL RESEARCH Vol. 151 No. 2 p. 344-353 1984 Research paper (scientific journal)

  123. Monoclonal antibody against diphtheria toxin. Effect of toxin binding and entry into cells.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 258 No. 7 p. 4311-4317 1983/04 Research paper (scientific journal)

  124. Methylamine facilitates demonstration of specific uptake of diphtheria toxin by CHO cell and toxinresistant CHO cell mutants.

    MEKADA Eisuke

    Biochem. Biophys. Res. Commun. Vol. 109 No. 3 p. 792-799 1982/04 Research paper (scientific journal)

  125. Methylamine stimulates the action of ricin toxin but inhibits that of diphtheria toxin.

    MEKADA Eisuke

    J. Biol. Chem. Vol. 256 No. 3 p. 1225-1228 1981/04 Research paper (scientific journal)

  126. Hybrid toxin of the A chain of ricin toxin and a subunit of Wistaria floribunda lectin.

    MEKADA Eisuke

    J. Biol. Chem. 1980/04 Research paper (scientific journal)

  127. Antibodies introduced into living cells by red cell ghosts are functionally stable in the cytoplasm of the cells.

    MEKADA Eisuke

    Cell 1979/04 Research paper (scientific journal)

  128. Modification of the cell surface with neuraminidase increases the sensitivities of cells to diphtheria tixin and Pseudomonas aeruginosa exotoxin.

    MEKADA Eisuke

    Exptl. Cell Res. 1979/04 Research paper (scientific journal)

  129. Improved methods using HVJ (Sendai virus) for introducing substaces into cells.

    MEKADA Eisuke

    Biochem. Biophys. Res. Commun. 1979/04 Research paper (scientific journal)

  130. One molecule of diphtheria toxin fragment A into a cell can kill the cell.

    MEKADA Eisuke

    Cell 1978/04 Research paper (scientific journal)

  131. Reconstitution of hybrid toxin from fragment A of diphtheria toxin and a subunit of Wistaria floribunda.

    MEKADA Eisuke

    J. Biol. Chem. 1978/04 Research paper (scientific journal)

  132. Quantitative introduction of a given macromolecule into cells by fusion with erythrocyte ghosts using a fluorescence activated cell sorter.

    MEKADA Eisuke

    J. Histochem. Cytochem. 1978/04 Research paper (scientific journal)

  133. An attempt to separate mononuclear cells fused with human red blood cell-ghosts from a cell mixture treated with HVJ (Sendai virus) using a fluorescence activated cell sorter (FACS (]G0002[)).

    MEKADA Eisuke

    J. Histochem. Cytochem. 1978/04 Research paper (scientific journal)

  134. Modification of cell membranes with viral envelopes during fusion of cells whth HVJ (Sendai virus) (]G0003[). Effects of mono- and di-saccharides on cell fusion and membrane movement of fused cells.

    MEKADA Eisuke

    Exptl. Cell Res. 1977/04 Research paper (scientific journal)

Misc. 119

  1. RNA干渉効率の向上を目指した抗体修飾脂質ナノ粒子の開発

    岡田憲明, 岡本彩香, 清水広介, 浅井知浩, 南野哲男, 目加田英輔, 奥直人

    日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会講演要旨集 Vol. 24th-2014 2014

  2. HB‐EGF標的化リポソームの開発

    西川薫, 重松宏和, 浅井知浩, 南野哲男, 朝野仁裕, 高島成二, 目加田英輔, 奥直人

    日本薬学会年会要旨集 Vol. 130th No. 4 p. 198-198 2010/03/05

    Publisher: (公社)日本薬学会
  3. Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures.

    Mizushima, H, Wang, X, Miyamoto, S, Mekada, E

    J. Cell Sci. Vol. 122 No. 23 p. 4277-4286 2009/11

  4. 体外受精に失敗したマウス未受精卵からの単為発生胚由来ES細胞の樹立とその利用

    堀居拓郎, 木村美香, 森田純代, 長尾恭光, 岩本亮, 目加田英輔, 畑田出穂

    J Reprod Dev Vol. 55 No. Supplement 2009/08/25

  5. HB‐EGF標的化リポソームによる新規ターゲティングDDSの開発

    重松宏和, 浅井知浩, 南野哲男, 朝野仁裕, 高島成二, 目加田英輔, 奥直人

    Drug Delivery System Vol. 24 No. 3 2009/06/09

  6. RCAS1 induces apoptosis in cells expressing its putative receptor via ectodomain shedding mediated by ADAM9

    Kenzo Sonoda, Shingo Miyamoto, Manabu Nakashima, Hiroaki Kobayashi, Eisuke Mekada, Norio Wake

    CANCER RESEARCH Vol. 69 2009/05 Research paper, summary (international conference)

  7. Synergistic antitumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.

    Yagi H, Yotsumoto F, Sonoda K, Kuroki M, Mekada E, Miyamoto S

    Int J Cancer. Vol. 124 No. 6 p. 1429-1439 2009/03

  8. HB-EGF.

    Mekada, E, Iwamoto, R

    UCSD-Nature Molecule Pages. 2008/11

  9. The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice.

    Miyado K, Yoshida K, Yamagata K, Sakakibara K, Okabe M, Wang X, Miyamoto K, Akutsu H, Kondo T, Takahashi Y, Ban T, Ito C, Toshimori K, Nakamura A, Ito M, Miyado M, Mekada E, Umezawa A

    Proc Natl Acad Sci U S A. Vol. 105 No. 35 p. 12921-12926 2008/08

  10. Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes COPD-like phenotype in mice.

    Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, Suzuki M, Minami S, Iwasaki T, Goya S, Kijima T, Kumagai T, Yoshida M, Osaki T, Komori T, Mekada E, Kawase I

    J. Biol. Chem. Vol. 283 No. 38 p. 26089-26097 2008/07

  11. Possible involvement of CD81 in acrosome reaction of sperm in mice.

    Tanigawa, M, Miyamoto, K, Kobayashi, S, Sato, M, Akutsu, H, Okabe, M, Mekada, E, Sakakibara, K, Miyado, M, Umezawa, A, Miyado, K

    Mol Reprod Dev. Vol. 75 No. 1 p. 150-155 2008/03

  12. HB-EGF decelerates cell proliferation synergistically with TGF-a in perinatal distal lung development.

    Minami, S, Iwamoto, R, Mekada, E

    Dev. Dyn. Vol. 237 No. 1 p. 247-258 2008/02

  13. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

    Yotsumoto, F, Yagi, H, Suzuki, S.O, Oki, E, Tsujioka, H, Hachisuga, T, Sonoda, K, Kawarabayashi, T, Mekada, E, Miyamoto, S

    Biochem Biophys Res Commun. Vol. 365 No. 3 p. 555-561 2008/02

  14. Validation of HB-EGF and amphiregulin as targets for human cancer therapy

    Fusanorl Yotsumoto, Hiroshi Yagi, Satoshi O. Suzuki, Eiji Oki, Hiroshi Tsujioka, Touru Hachisuga, Kenzo Sonoda, Tatsuhiko Kawarabayashi, Eisuke Mekada, Shingo Miyamoto

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 365 No. 3 p. 555-561 2008/01

  15. HB-EGF decelerates cell proliferation synergistically with TGFα in perinatal distal lung development

    Seigo Minami, Ryo Iwamoto, Eisuke Mekada

    Developmental Dynamics Vol. 237 No. 1 p. 247-258 2008/01

  16. Possible involvement of CD81 in acrosome reaction of sperm in mice

    Maya Tanigawa, Kiyoko Miyamoto, Satoshi Kobayashi, Masahiro Sato, Hidenori Akutsu, Masaru Okabe, Eisuke Mekada, Keiichi Sakakibara, Mami Miyado, Akihiro Umezawa, Kenji Miyado

    MOLECULAR REPRODUCTION AND DEVELOPMENT Vol. 75 No. 1 p. 150-155 2008/01

  17. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer

    Kenzo Sonoda, Shingo Miyamoto, Ayano Yamazaki, Hiroaki Kobayashi, Manabu Nakashima, Eisuke Mekada, Norio Wake

    CANCER Vol. 110 No. 9 p. 1979-1990 2007/11

  18. Sulfated glycosaminoglycans are necessary for Nodal signal transmission from the node to the left lateral plate in the mouse embryo

    Shinya Oki, Ryuju Hashimoto, Yuko Okui, Michael M. Shen, Eisuke Mekada, Hiroki Otani, Yukio Saijoh, Hiroshi Hamada

    DEVELOPMENT Vol. 134 No. 21 p. 3893-3904 2007/11

  19. Maternal heparin-binding-EGF deficiency limits pregnancy success in mice

    Huirong Xie, Haibin Wang, Susanne Tranguch, Ryo Iwamoto, Eisuke Mekada, Francesco J. DeMayo, John P. Lydon, Sanjoy K. Das, Sudhansu K. Dey

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Vol. 104 No. 46 p. 18315-18320 2007/11

  20. Maternal heparin-binding-EGF deficiency limits pregnancy success in mice.

    Xie, H, Wang, H, Tranguch, S, Iwamoto, R, Mekada, E, DeMayo, F. J, Lydon, J. P, Das S. K, Dey, S. K

    Proc. Natl. Acad. Sci. USA Vol. 104 No. 46 p. 18315-18320 2007/09

  21. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.

    Sonoda, K, Miyamoto, S, Yamazaki, A, Kobayashi, H, Nakashima, M, Mekada, E, Wake, N

    Cancer Vol. 110 No. 9 p. 1979-1990 2007/09

  22. Sulfated glycosaminoglycans are necessary for Nodal signal transmission from the node to the left lateral plate in the mouse embryo.

    Oki, S, Hashimoto, R, Okui, Y, Shen, M.M, Mekada, E, Otani, H, Saijoh, Y, Hamada, H

    Development Vol. 134 No. 21 p. 3893-3904 2007/09

  23. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.

    Kageyama, T, Ohishi, M, Miyamoto, S, Mizushima, H, Iwamoto, R, Mekada, E

    J. Biochem. Vol. 142 No. 1 p. 95-104 2007/06

  24. Parasporin-1, a novel cytotoxic protein from Bacillus thuringiensis, induces Ca2+ influx and a sustained elevation of the cytoplasmic Ca2+ concentration in toxin-sensitive cells.

    Katayama, H, Kusaka, Y, Yokota, H, Akao, T, Kojima, M, Nakamura, O, Mekada, E, Mizuki. E

    J. Biol. Chem. Vol. 282 No. 10 p. 7742-7752 2007/03

  25. Parasporin-1, a novel cytotoxic protein from Bacillus thuringiensis, induces Ca2+ influx and a sustained elevation of the cytoplasmic Ca2+ concentration in toxin-sensitive cells

    Hideki Katayama, Yoshitomo Kusaka, Haruo Yokota, Tetsuyuki Akao, Masayasu Kojima, Osamu Nakamura, Eisuke Mekada, Eiich Mizuki

    JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 282 No. 10 p. 7742-7752 2007/03

  26. siRNAライブラリーを用いたジフテリア毒素の作用機構に関わる宿主因子の網羅的解析

    横田 春生, 大石 美奈子, 目加田 英輔

    日本細菌学雑誌 Vol. 62 No. 1 p. 109-109 2007/02/25

  27. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.

    J. Biochem. Vol. 142 No. 1 p. 95-104 2007

  28. Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation

    Daisuke Nanba, Yumi Kinugasa, Chie Morimoto, Michiko Koizumi, Hisako Yamamura, Katsuhito Takahashi, Nobuyuki Takakura, Eisuke Mekada, Koji Hashimoto, Shigeki Higashiyama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 350 No. 2 p. 315-321 2006/11

  29. Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation.

    Nanba, D, Kinugasa, Y, Morimoto, C, Koizumi, M, Yamamura, H, Takahashi, K, Takakura, N, Mekada, E, Hashimoto, K, Higashiyama, S

    Biochem Biophys Res Commun. Vol. 350 No. 2 p. 315-321 2006/09

  30. Heparin-binding EGF-like growth factor as a novel targeting molecule for cancer therapy.

    Miyamoto, S, Yagi, H, Yotsumoto, F, Kawarabayashi, T, Mekada, E

    Cancer Sci. Vol. 97 2006/05

  31. FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts

    K Kakumoto, K Sasai, T Sukezane, C Oneyama, S Ishimaru, K Shibutani, H Mizushima, E Mekada, H Hanafusa, T Akagi

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Vol. 103 No. 14 p. 5490-5495 2006/04

  32. FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.

    Kakumoto, K, Sasai, K, Sukezane, T, Oneyama, C, Ishimaru, S, Shibutani, K, Mizushima, H, Mekada, E, Hanafusa, H, Akagi, T

    Proc. Natl. Acad. Sci. USA Vol. 103 No. 14 p. 5490-5495 2006/04

  33. Cytoplasmic Domain Phosphorylation of Heparin-Binding EGF-like Growth Factor.

    Wang, X, Mizushima, H, Adachi, S, Ohishi, M, Iwamoto, R, Mekada, E

    Cell Struct. Funct. Vol. 31 No. 1 p. 15-27 2006/01

  34. ErbB and HB-EGF signaling in heart development and function.

    Iwamoto, R, Mekada, E

    Cell Struct. Funct. Vol. 31 No. 1 p. 1-14 2006/01

    Publisher: Japan Society for Cell Biology
  35. "Toxin receptors" in The comprehensive Sourcebook of Bacterial Protein Toxins

    Academic Press 2006

  36. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor

    Xiaobiao Wang, Hiroto Mizushima, Satoshi Adachi, Minako Ohishi, Ryo Iwamoto, Eisuke Mekada

    Cell Structure and Function Vol. 31 No. 1 p. 15-27 2006

  37. ErbB and HB-EGF signaling in heart development and function.

    Ryo Iwamoto, Eisuke Mekada

    Cell Struct. Funct. Vol. 31 No. 1 p. 1-14 2006

  38. Heparin-binding EGF-like growth factor as a novel targeting molecule for cancer therapy.

    Cancer Sci. Vol. 97 2006

  39. "Toxin receptors" in The comprehensive Sourcebook of Bacterial Protein Toxins

    Academic Press 2006

  40. HB-EGF promotes epithelial cell migration in eyelid development.

    Mine, N, Iwamoto, R, Mekada, E

    Development Vol. 132, 4317-4326/, p. 4317-4326 2005/10

  41. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia.

    Kimura, R, Iwamoto, R, Mekada, E

    Cell Struct. Funct. Vol. 30 No. 1 p. 35-42 2005/09

  42. Clinical significance of heparin-binding EGF (epidermal growth factor)-like growth factor and ADAM (a disintegrin and metalloprotease) 17 expression in human ovarian cancer.

    Tanaka, T, Miyamoto, S, Suzuki, S. O, Oki, E, Yagi, H, Sonoda, K, Yamazaki, A, Mizushima, H, Maehara, Y, Mekada, E, Nakano, H

    Clin. Cancer Res. Vol. 11 No. 13 p. 4783-4792 2005/08

  43. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer

    Y Tanaka, S Miyamoto, SO Suzuki, E Oki, H Yagi, K Sonoda, A Yamazaki, H Mizushima, Y Maehara, E Mekada, H Nakano

    CLINICAL CANCER RESEARCH Vol. 11 No. 13 p. 4783-4792 2005/07

  44. Inhibitory effect of N-acetyl-L-cysteine on TPA-induced shedding of HB-EGF

    Toshiyuki Umata, Eisuke Mekada, Toshiyuki Norimura

    CELL STRUCTURE AND FUNCTION Vol. 30 p. 83-83 2005/06 Research paper, summary (international conference)

  45. HB-EGF bioactivity is changed by association with heparan sulfate proteoglycans

    Risa Takazaki, Ryo Iwamoto, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 30 p. 34-34 2005/06 Research paper, summary (international conference)

  46. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.

    Shirakata, Y, Kimura,K, Nanba, D, Iwamoto, R, Tokumaru, S, Morimoto, C, Yokota, K, Nakamura, M, Sayama, K, Mekada, E, Higashiyama, S, Hashimoto. K

    J. Cell Sci. Vol. 118 No. 11 p. 2363-2370 2005/06

  47. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing

    Y Shirakata, R Kimura, D Nanba, R Iwamoto, S Tokumaru, C Morimoto, K Yokota, M Nakamura, K Sayama, E Mekada, S Higashiyama, K Hashimoto

    JOURNAL OF CELL SCIENCE Vol. 118 No. 11 p. 2363-2370 2005/06

  48. HB-EGF promotes epithelial cell migration in eyelid development

    Naoki Mine, Ryo Iwamoto, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 30 p. 55-55 2005/06 Research paper, summary (international conference)

  49. Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer

    H Yagi, S Miyamoto, Y Tanaka, K Sonoda, H Kobayashi, T Kishikawa, R Iwamoto, E Mekada, H Nakano

    BRITISH JOURNAL OF CANCER Vol. 92 No. 9 p. 1737-1745 2005/05

  50. Clinical significance of heparin-binding epidermal growth factor-Like growth factor in peritoneal fluid of ovarian cancer.

    Yagi, H, Miyamoto, S, Tanaka, Y, Sonoda, K, Kobayashi, H, Kishikawa, T, Iwamoto, R, Mekada, E, Nakano, H

    Brit. J. Cancer Vol. 92 No. 9 p. 1737-1745 2005/05

  51. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia

    Rina Kimura, Ryo Iwamoto, Eisuke Mekada

    Cell Structure and Function Vol. 30 No. 2 p. 35-42 2005

  52. Parasporin-1, a novel cytotoxic protein to human cells from non-insecticidal parasporal inclusions of Bacillus thuringiensis

    H Katayama, H Yokota, T Akao, O Nakamura, M Ohba, E Mekada, E Mizuki

    JOURNAL OF BIOCHEMISTRY Vol. 137 No. 1 p. 17-25 2005/01

  53. Parasporin-1, a novel cytotoxic protein to human cells from non-insecticidal parasporal inclusions of Bacillus thuringiensis.

    Katayama, H, Yokota, H, Akao, T, Nakamura, O, Ohba, O, Mekada, E, Mizuki, E

    J. Biochem. Vol. 137 No. 1 p. 17-25 2005/01

  54. HB-EGF promotes epithelial cell migration in eyelid development.

    Development Vol. 132, 4317-4326 2005

  55. Mice with defects in HB-EGF and its ectodomain shedding show severe developmental abnormalities

    R Iwamoto, S Yamazaki, K Saeki, S Takashima, S Itami, G Yamada, M Klagsbrun, E Mekada

    MOLECULAR BIOLOGY OF THE CELL Vol. 15 p. 452A-452A 2004/11 Research paper, summary (international conference)

  56. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor

    R Takazaki, Y Shishido, R Iwamoto, E Mekada

    JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279 No. 45 p. 47335-47343 2004/11

  57. Tetraspanin protein (TSP-15) integrity is required for epidermal integrity in Caenorhabditis elegans

    H Moribe, J Yochem, H Yamada, Y Tabuse, T Fujimoto, E Mekada

    JOURNAL OF CELL SCIENCE Vol. 117 No. 22 p. 5209-5220 2004/10

  58. Requirement for TSP-15, a tetraspanin protein, for epidermal integrity in Caenorhabditis elegans.

    Moribe, H, Yochem, J, Yamada, H, Tabuse, Y, Fujimoto, T, Mekada, E

    J. Cell Sci. 2004/10

  59. Suppression of the biological activities of the EGF-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor.

    Takazaki, R, Shishido, Y, Iwamoto, R, Mekada, E

    J. Biol. Chem. 2004/10

  60. Heparin-binding EGF-like growth factor and the LPA-induced ectodomain shedding pathway is a promising target for the therapy of ovarian cancer.

    Miyamoto, S, Hirata, M, Yamazaki, A, Kageyama, T, Hasuwa, H, Mizushima, H, Tanaka, Y, Yagi, H, Sonoda, K, Kai, M, Kanoh, H, Nakano, H, Mekada, E

    Cancer Res. Vol. 64 No. 16 p. 5720-5727 2004/08

  61. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy

    S Miyamoto, M Hirata, A Yamazaki, T Kageyama, H Hasuwa, H Mizushima, Y Tanaka, H Yagi, K Sonoda, M Kai, H Kanoh, H Nakano, E Mekada

    CANCER RESEARCH Vol. 64 No. 16 p. 5720-5727 2004/08

  62. Heparin-binding EGF-like Growth Factor Is a Promising Target for the Therapy of Ovarian Cancer

    Miyamoto Shingo, Yagi Hiroshi, Tanaka Yoshihiro, Sonoda Kenzo, Nakano Nitoo, Mekata Eisuke

    Connective tissue Vol. 36 No. 2 p. 104-104 2004/06/03

    Publisher: The Japanese Society for Connective Tissue
  63. A tetraspanin protein TSP-15 is required for epidermal integrity in C-elegans

    Hiroki Moribe, John Yochem, Hiromi Yamada, Yo Tabuse, Toyoshi Fujimoto, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 29 p. 51-51 2004/05 Research paper, summary (international conference)

  64. The biological activity of HB-EGF is modulated by its heparin-binding domain and by association with heparan sulfate proteoglycans

    Risa Takazaki, Ryo Iwamoto, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 29 p. 76-76 2004/05 Research paper, summary (international conference)

  65. TIMP-sensitive proteases are required for HB-EGF-induced tumorigenesis independent of mediating ectodomain shedding

    Hiroto Mizushima, Xiobion Wan, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 29 p. 75-75 2004/05 Research paper, summary (international conference)

  66. HB-EGF is required for normal cardiac development

    Naoki Mine, Ryo Iwamoto, Ikuyo Ishimatu, Eisuke Mekada

    CELL STRUCTURE AND FUNCTION Vol. 29 p. 76-76 2004/05 Research paper, summary (international conference)

  67. Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation.

    Ishibashi, T, Ding, L, Ikenaka, K, Inoue, Y, Miyado, K, Mekada, E, Baba, H

    J. Neurosci., 24, 96-102. Vol. 24 No. 1 p. 96-102 2004/01

  68. Suppression of the biological activities of the EGF-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor.

    J. Biol. Chem. 2004

  69. Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation

    T Ishibashi, L Ding, K Ikenaka, Y Inoue, K Miyado, E Mekada, H Baba

    JOURNAL OF NEUROSCIENCE Vol. 24 No. 1 p. 96-102 2004/01

  70. Requirement for TSP-15, a tetraspanin protein, for epidermal integrity in Caenorhabditis elegans.

    J. Cell Sci. 2004

  71. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.

    Yamazaki, S, Iwamoto, R, Saeki, K, Asakura, M, Takashima, S, Yamazaki, A, Kimura, R, MIzushima. H, Moribe, H, Higashiyama, S, Endoh, M, Kaneda, Y, Takagi, S, Itami, S, Takeda, N, Yamada, G, Mekada, E

    J. Cell Biol., 163, 469-475. Vol. 163 No. 3 p. 469-475 2003/11

  72. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities

    S Yamazaki, R Iwamoto, K Saeki, M Asakura, S Takashima, A Yamazaki, R Kimura, H Mizushima, H Moribe, S Higashiyama, M Endoh, Y Kaneda, S Takagi, S Itami, N Takeda, G Yamada, E Mekada

    JOURNAL OF CELL BIOLOGY Vol. 163 No. 3 p. 469-475 2003/11

  73. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes

    Y Takeda, Tachibana, I, K Miyado, M Kobayashi, T Miyazaki, T Funakoshi, H Kimura, H Yamane, Y Saito, H Goto, T Yoneda, M Yoshida, T Kumagai, T Osaki, S Hayashi, Kawase, I, E Mekada

    JOURNAL OF CELL BIOLOGY Vol. 161 No. 5 p. 945-956 2003/06

  74. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

    Takeda, Y, Tachibana, I, Miyado, K, Kobayashi, M, Miyazaki, T, Funakoshi, T, Kimura, H, Yamane, H, Saito, Y, Goto, H, Yoneda, T, Yoshida, M, Kumagai, T, Osaki, T, Hayashi, S, Kawase, I, Mekada, E

    J. Cell Biol., 161, 945-956. Vol. 161 No. 5 p. 945-956 2003/06

  75. HB-EGF Is an Essential Growth Factor for Cardiomyocyte Metabolism : The Possibility for a Novel Therapeutic Target for Heart Failure

    Takashima Seiji, Kitakaze Masafumi, Asakura Masanori, Mekada Eisuke, Asano Yoshihiro, Shintani Yasunori, Hori Masatsugu

    Circulation journal : official journal of the Japanese Circulation Society Vol. 67 p. 11-11 2003/03/01

    Publisher: Japanese Circulation Society
  76. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

    R Iwamoto, S Yamazaki, M Asakura, S Takashima, H Hasuwa, K Miyado, S Adachi, M Kitakaze, K Hashimoto, G Raab, D Nanba, S Higashiyama, M Hori, M Klagsbrun, E Mekada

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Vol. 100 No. 6 p. 3221-3226 2003/03

  77. The stress- and the inflammatory cytokine-induced ectodomain shedding of heparin-binding EGF-like growth factor is mediated by p38 MAPK, distinct from TPA-induced and LPA-induced signaling cascades.

    Takenobu, H, Yamazaki, A, Hirata, M, Umata, T, Mekada, E

    J. Biol. Chem., 278, 17255-17262. Vol. 278, 17255-17262/, 2003/02

  78. 147 Activation of heparin-binding EGF-like Growth factor by various stress(Signal transduction, Abstracts of the 46th Annual Meeting of the Japan Radiation Research Society) :

    UMATA Toshiyuki, TAKENOBU Hisanori, MEKADA Eisuke, NORIMURA Toshiyuki

    Journal of radiation research Vol. 44 No. 4 p. 423-423 2003

    Publisher: the Japan Radiation Research Society
  79. The stress- and the inflammatory cytokine-induced ectodomain shedding of heparin-binding EGF-like growth factor is mediated by p38 MAPK, distinct from TPA-induced and LPA-induced signaling cascades.

    J. Biol. Chem. Vol. 278, 17255-17262/, 2003

  80. CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors

    M Kawashima, K Doh-ura, E Mekada, M Fukui, T Iwaki

    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY Vol. 50 No. 9 p. 1195-1203 2002/09

  81. CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors.

    Kawashima, M, Doh-ura, K, Mekada, E, Fukui, M, Iwaki, T

    J. Histochem. Cytochem. Vol. 50 No. 9 p. 1195-1203 2002/09

  82. Ligand-independent dimer formation of EGFR is a step separable from ligand-induced EGFR signaling.

    Yu, X, Sharma, K. D, Takahashi, T, Iwamoto, R, Mekada, E

    Mol. Biol. Cell Vol. 13 No. 7 p. 2547-2557 2002/07

  83. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling

    XC Yu, KD Sharma, T Takahashi, R Iwamoto, E Mekada

    MOLECULAR BIOLOGY OF THE CELL Vol. 13 No. 7 p. 2547-2557 2002/07

  84. Elevated cerebrospinal fluid levels of anti-CD9 antibodies in patients with subacute sclerosing panencephalitis.

    Shimizu, T, Matsuishi, T, Iwamoto, R, Handa, K, Yoshioka, H, Kato, H, Ueda, S, Hara, H, Tabira, T, Mekada, E

    J. Infect. Dis. Vol. 185 No. 9 p. 1346-1350 2002/06

  85. Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis

    T Shimizu, T Matsuishi, R Iwamoto, K Handa, H Yoshioka, H Kato, S Ueda, H Hara, T Tabira, E Mekada

    JOURNAL OF INFECTIOUS DISEASES Vol. 185 No. 9 p. 1346-1350 2002/05

  86. CD9 and gamete membrane fusion(Symposium on the Mechanism of Signal Transduction in Fertilization: its Diversity, Universality and Evolution) :

    Miyado Kenji, Okabe Masaru, Mekada Eisuke

    Zoological science Vol. 19 No. 12 p. 1409-1410 2002

    Publisher: Zoological Society of Japan
  87. Accelerated signal transduction depending on pre-clustering of epidermal growth factor receptor: A single-molecule analysis

    Y Sako, XC Yu, E Mekada, T Yanagida

    BIOPHYSICAL JOURNAL Vol. 82 No. 1 p. 217A-217A 2002/01 Research paper, summary (international conference)

  88. CD9 amino acids critical for upregulation of diphtheria toxin binding.

    Hasuwa, H, Shishido, Y, Yamazaki, A, Kobayashi, T, Yu, X, Mekada, E

    Biochem. Biophys. Res. Commun. Vol. 289 No. 4 p. 782-790 2001/12

  89. CD9 amino acids critical for upregulation of diphtheria toxin binding

    H Hasuwa, Y Shishido, A Yamazaki, T Kobayashi, XC Yu, E Mekada

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 289 No. 4 p. 782-790 2001/12

  90. Signaling cascade of the ectodomain shedding of HB-EGF

    HIRATA Michinari, UMATA Toshiyuki, YU Xiauchu, TAKENOBU Hisanori, MEKADA Eisuke

    Vol. 50 p. 87-87 2001/10/01

  91. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice

    M Saito, T Iwawaki, C Taya, H Yonekawa, M Noda, Y Inui, E Mekada, Y Kimata, A Tsuru, K Kohno

    NATURE BIOTECHNOLOGY Vol. 19 No. 8 p. 746-750 2001/08

  92. A dual signaling cascade that regulates the ectodomain shedding of HB-EGF.

    Umata, T, Hirata, M, Takahashi, T, Ryu, F, Shida, S, Takahashi, Y, Tsuneoka, M, Miura, Y, Masuda, M, Horiguchi, Y, Mekada, E

    J. Biol. Chem. Vol. 276, 30475-30482/, 2001/08

  93. Identification of serum factor inducing ectodomain shedding of proHB-EGF and studies of non-cleavable mutants of proHB-EGF.

    Hirata, M, Umata, T, Takahashi, T, Ohnuma, M, Miura, Y, Iwamoto R, Mekada, E

    Biochem. Biophys. Res. Commun. Vol. 283 No. 4 p. 915-922 2001/08

  94. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice.

    Saito, M, Iwawaki, T, Taya, C, Yonekawa, H, Munehiro, N, Inui, Y, Mekada, E, Kimata, Y, Tsuru, A, Kohno, K

    Nat. Biotechnol. Vol. 19 No. 8 p. 746-750 2001/08

  95. Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis.

    Kusukawa, J, Ryu, F, Kameyama, T, Mekada, E

    J. Oral Pathol. Med. Vol. 30 No. 2 p. 73-79 2001/07

  96. Identification of serum factor inducing ectodomain shedding of proHB-EGF and studies of noncleavable mutants of proHB-EGF

    M Hirata, T Umata, T Takahashi, M Ohnuma, Y Miura, R Iwamoto, E Mekada

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 283 No. 4 p. 915-922 2001/05

  97. Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor, and integrin alpha 3 beta 1 in normal human tissues

    Y Nakamura, K Handa, R Iwamoto, T Tsukamoto, M Takahasi, E Mekada

    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY Vol. 49 No. 4 p. 439-444 2001/04

  98. Extension of juxtamembrane domain of diphtheria toxin receptor arrests translocation of diphtheria toxin fragment A into cytosol.

    Takahashi, T, Umata, T, Mekada, E

    Biochem. Biophys. Res. Commun. Vol. 281 No. 3 p. 690-696 2001/04

  99. Extension of juxtamembrane domain of diphtheria toxin receptor arrests translocation of diphtheria toxin fragment A into cytosol

    T Takahashi, T Umata, E Mekada

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 281 No. 3 p. 690-696 2001/03

  100. Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis

    J Kusukawa, F Ryu, T Kameyama, E Mekada

    JOURNAL OF ORAL PATHOLOGY & MEDICINE Vol. 30 No. 2 p. 73-79 2001/02

  101. A dual signaling cascade that regulates the ectodomain shedding of HB-EGF.(共著)

    J. Biol. Chem. Vol. 276, 30475-30482/, 2001

  102. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells

    Baba, I, S Shirasawa, R Iwamoto, K Okumura, T Tsunoda, M Nishioka, K Fukuyama, K Yamamoto, E Mekada, T Sasazuki

    CANCER RESEARCH Vol. 60 No. 24 p. 6886-6889 2000/12

  103. Domain analysis of the tetraspanins: Studies of CD9/CD63 chimeric molecules on subcellular localization and upregulation activity for diphtheria toxin binding

    F Ryu, T Takahashi, K Nakamura, Y Takahashi, T Kobayashi, S Shida, T Kameyama, E Mekada

    CELL STRUCTURE AND FUNCTION Vol. 25 No. 5 p. 317-327 2000/10

  104. Domain analysis of the tetraspanins: Studies of CD9/CD63 chimeric molecules on subcellular localization and upregulation activity for diphtheria toxin binding

    F Ryu, T Takahashi, K Nakamura, Y Takahashi, T Kobayashi, S Shida, T Kameyama, E Mekada

    CELL STRUCTURE AND FUNCTION Vol. 25 No. 5 p. 317-327 2000/10

  105. ヒトTom22のクローニングと機能解析

    佐伯 和子, 鈴木 寛之, 常岡 誠, 前田 真希, 阪口 雅郎, 遠藤 斗志也, 三浦 芳樹, 目加田 英輔, 三原 勝芳

    生化学 Vol. 72 No. 8 p. 812-812 2000/08/25

    Publisher: (公社)日本生化学会
  106. Heparin-binding EGF-like growth factor : a juxtacrine growth factor.

    MEKADA Eisuke

    Cytokine & Growth Factor Reviews Vol. 11 No. 4 p. 335-344 2000/04 Book review, literature introduction, etc.

  107. Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor and integrin a3bl in normal human tissues.

    MEKADA Eisuke

    J. Histochem. Cytochem. Vol. 49 No. 4 p. 439-444 2000/04

  108. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cencer cells.

    MEKADA Eisuke

    Cancer Res. Vol. 60 No. 24 p. 6886-6889 2000/04

  109. A crucial role of tetraspanin, CD9 in fertilization

    K. Miyado, E. Mekada, K. Kobayashi

    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme Vol. 45 No. 10 p. 1728-1734 2000 Book review, literature introduction, etc.

  110. Signal transducion of epidermal growth factro (EGF) is accelerated by pre-clustering of EGF receptor

    Sako Y., Yu X., Mekada E., Yanagida T.

    Seibutsu Butsuri Vol. 40 No. 0 2000

    Publisher: The Biophysical Society of Japan General Incorporated Association
  111. Expression or heparin-binding epidermal growth factor-like growth factor in hepatocellular carcinoma and noncancerous tissues.

    K Higaki, H Yano, M Haramaki, Y Shishido, S Ogasawa, J Akiba, E Mekada, M Kojiro

    HEPATOLOGY Vol. 30 No. 4 p. 260A-260A 1999/10 Research paper, summary (international conference)

  112. CD9 reduces xenotransplantability of human hepatoma cells into nude mice.

    M Haramaki, H Yano, Y Shishido, K Higaki, E Mekada, M Kojiro

    HEPATOLOGY Vol. 28 No. 4 p. 513A-513A 1998/10 Research paper, summary (international conference)

  113. Institute of Life Science, Kurume University

    MEKADA E.

    Vol. 68 No. 9 p. 1572-1573 1996/09/25

  114. 膜4回貫通型タンパク質 CD9 とそのファミリー

    目加田 英輔

    生化学 Vol. 67 No. 3 p. 224-228 1995/03/25

    Publisher: 日本生化学会
  115. PARTIAL-PURIFICATION OF DIPHTHERIA-TOXIN RECEPTOR

    E MEKADA, H SENOH, Y OKADA, T UCHIDA

    CELL STRUCTURE AND FUNCTION Vol. 12 No. 6 p. 676-676 1987/12 Research paper, summary (international conference)

  116. PARTIAL-PURIFICATION OF DIPHTHERIA-TOXIN RECEPTOR

    E MEKADA, H SENOH, Y OKADA, T UCHIDA

    CELL STRUCTURE AND FUNCTION Vol. 11 No. 4 p. 488-488 1986/12 Research paper, summary (international conference)

  117. CHARACTERIZATION AND APPLICATION OF MONOCLONAL-ANTIBODIES AGAINST DIPHTHERIA-TOXIN FRAGMENT-A

    T YOSHIMORI, M YAMADA, H SUGAWA, E MEKADA, T UCHIDA, Y OKADA

    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY Vol. 37 No. 4 p. 199-199 1984 Research paper, summary (international conference)

  118. MONOCLONAL-ANTIBODIES AGAINST DIPHTHERIA-TOXIN AND ANALYSIS OF DIPHTHERIA-TOXIN USING THEM

    S HAYAKAWA, T UCHIDA, E MEKADA, K TAKAMATSU, Y OKADA

    CELL STRUCTURE AND FUNCTION Vol. 6 No. 4 p. 434-434 1981 Research paper, summary (international conference)

  119. TRANSDIFFERENTIATION OF NEURONAL CELLS SEPARATED BY CELL SORTER

    K NOMURA, E MEKADA, S TAKAGI, TS OKADA

    DEVELOPMENT GROWTH & DIFFERENTIATION Vol. 23 No. 4 p. 449-449 1981 Research paper, summary (international conference)

Publications 14

  1. Mathematical Modeling for Break Down of Dynamical Equilibrium in Bone Metabolism

    T.Suzuki, K.Itano, R.Zou, R.Iwamoto, E.Mekada

    Springer 2017/01 Scholarly book

    ISBN: 9789811009624

  2. "Toxin receptors" in The comprehensive Sourcebook of Bacterial Protein Toxins

    Horiguchi, Y, Mekada, E

    Academic Press 2006/06 Scholarly book

  3. Diphtheria toxin and the diphtheria-toxin receptor in Handbook of Experimental Pharmacology ed. By Aktories K. and Just I.

    2000 Other

  4. Diphtheria toxin and the diphtheria-toxin receptor in "Handbook of Experimental Pharmacology" ed. By Aktories K. and Just I.

    Springer-Verlag, Berlin 2000

  5. Diphtheria toxin and the diphtheria-toxin receptor in "Handbook of Experimental Pharmacology" ed. By Aktories K. and Just I.

    Springer-Verlag, Berlin 2000

  6. The Diphtheria Toxin Receptor. in Handbook of natural toxins : Volume 8, Bacterial toxins and virulence factors in disease ed. by Moss, J. , Iglewski, B. , Vaughan, M. & Tu, A. T.

    1995 Other

  7. The Diphtheria Toxin Receptor. in "Handbook of natural toxins : Volume 8, Bacterial toxins and virulence factors in disease" ed. by Moss, J. , Iglewski, B. , Vaughan, M. & Tu, A. T.

    Marcel Dekker Inc. , New York 1995

  8. The Diphtheria Toxin Receptor. in "Handbook of natural toxins : Volume 8, Bacterial toxins and virulence factors in disease" ed. by Moss, J. , Iglewski, B. , Vaughan, M. & Tu, A. T.

    Marcel Dekker Inc. , New York 1995

  9. Hybrid molecules. in Handbook of natural toxin : Volume 4, Bacterial toxins ed. by Hardegree, M. C. & Tu, A. T.

    1988 Other

  10. Hybrid molecules. in "Handbook of natural toxin : Volume 4, Bacterial toxins" ed. by Hardegree, M. C. & Tu, A. T.

    Marcel Dekker Inc. , New York 1988

  11. Hybrid molecules. in "Handbook of natural toxin : Volume 4, Bacterial toxins" ed. by Hardegree, M. C. & Tu, A. T.

    Marcel Dekker Inc. , New York 1988

  12. Methods using HVJ (Sendai virus) for introducing substances into viable mammalian cells. in Introduction of macromolecules into viable mammalian cellS ed. by Baserga, R.

    1980 Other

  13. Methods using HVJ (Sendai virus) for introducing substances into viable mammalian cells. in "Introduction of macromolecules into viable mammalian cellS" ed. by Baserga, R.

    Alan Liss Inc. 1980

  14. Methods using HVJ (Sendai virus) for introducing substances into viable mammalian cells. in "Introduction of macromolecules into viable mammalian cellS" ed. by Baserga, R.

    Alan Liss Inc. 1980

Industrial Property Rights 29

  1. ポリペプチド及び抗腫瘍剤

    目加田 英輔

    特許6422652

    出願日:2014/01/21

    登録日:2018/10/26

  2. THERAPEUTIC AGENT FOR CANCER

    MEKADA, Eisuke, MIYAMOTO, Shingo

    1894575

    出願日:2006/06

    登録日:2013/02

  3. 肺がん治療薬

    目加田 英輔, 宮本 新吾

    5110980

    出願日:2007/06

    登録日:2012/10

  4. 癌治療薬

    目加田 英輔, 宮本 新吾

    5052338

    出願日:2006/06

    登録日:2012/08

  5. Anticancer agent

    Mekada, Eisuke, Miyamoto, Shingo

    2005328131

    出願日:2005/08

    登録日:2011/08

  6. Therapeutic agent for cancer0

    Mekada, Eisuke,Miyamoto, Shingo

    7700546

    出願日:2006/06

    登録日:2010/04

  7. 制癌剤

    目加田英輔, 宮本新吾

    4203742

    出願日:2003/10

    登録日:2008/10

  8. 制癌剤

    目加田 英輔, 宮本 新吾

    出願日:2011/06/15

  9. 制癌剤

    目加田 英輔, 宮本 新吾

    特許第5769510号

    出願日:2011/06/15

  10. ANTICANCER AGENT

    Mekada, Eisuke, Miyamoto, Shingo

    出願日:2005/08

  11. トリプルネガティブ乳癌に対する制癌剤

    目加田 英輔, 宮本 新吾, 東 雍

    出願日:2009/03/25

  12. HB−EGF結合性タンパク質複合体

    南野 哲男, 目加田 英輔, 浅井 知浩, 高島 成二, 朝野 仁裕, 奥 直人

    出願日:2010/02/03

  13. アンフィレギュリン濃度に基づく絨毛膜羊膜炎の診断ならびに予防方法

    吉里 俊幸, 宮本 新吾, 瓦林 達比古, 目加田 英輔

    出願日:2006/09/04

  14. ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体

    目加田 英輔, 岩本 亮, 宮本 新吾, 設楽 研也, 古谷 安希子, 中村 和靖, 高橋 久美子, 安藤 博司, 桝田 和宏, 佐々木 由香

    出願日:2008/12/05

  15. 連続投与されたCRM197による抗腫瘍効果

    目加田 英輔, 宮本 新吾, 東 雍

    出願日:2007/07/09

  16. 肺がん治療薬

    目加田 英輔, 宮本 新吾

    特許第5110980号

    出願日:2007/06/26

  17. 制癌剤

    目加田 英輔, 宮本 新吾

    出願日:2008/05/30

  18. 分泌型ヘパリン結合上皮細胞増殖因子様増殖因子の測定方法

    目加田 英輔, 岩本 亮, 宮本 新吾, 設楽 研也, 古谷 安希子

    出願日:2007/06/06

  19. ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体

    目加田 英輔, 岩本 亮, 宮本 新吾, 設楽 研也, 古谷 安希子, 中村 和靖, 高橋 久美子, 安藤 博司, 桝田 和宏, 佐々木 由香

    出願日:2007/06/06

  20. 癌治療薬

    目加田 英輔, 宮本 新吾

    出願日:2006/06/20

  21. 制癌剤

    目加田 英輔, 宮本 新吾

    出願日:2005/02/25

  22. CD9/CD81二重欠損非ヒト動物

    目加田 英輔, 宮戸 健二, 立花 功, 武田 吉人

    出願日:2004/06/07

  23. 制癌剤

    目加田 英輔, 宮本 新吾

    出願日:2003/10/15

  24. ヘパリン結合性上皮増殖因子様増殖因子遺伝子機能改変動物、スクリーニング方法、胚性幹細胞、並びに心不全予防および/または治療薬

    高島成二, 北風政史, 目加田英輔, 東山繁樹, 朝倉正紀, 岩本亮, 山崎悟, 堀正二

    特願2002-141791号

    出願日:2002/05

  25. ヒトモノクローナル抗体

    目加田 英輔, 山田 修逸, 玉井 清

    出願日:1991/11/07

  26. HB-EGF結合性タンパク質複合体

    朝野仁裕ら

    特許第5299922号

    出願日:2011/08

  27. ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体

    目加田 英輔, 岩本 亮, 宮本 新吾, 設楽 研也, 古谷 安希子, 中村 和靖, 高橋 久美子, 安藤 博司, 桝田 和宏, 佐々木 由香

    特許第5532401号

    出願日:2008/12/05

  28. ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体

    目加田 英輔, 岩本 亮, 宮本 新吾, 設楽 研也, 古谷 安希子, 中村 和靖, 高橋 久美子, 安藤 博司, 桝田 和宏, 佐々木 由香

    特許第5586146号

    出願日:2007/06/06

  29. CD9/CD81二重欠損非ヒト動物

    目加田 英輔, 宮戸 健二, 立花 功, 武田 吉人

    特許第4696316号

    出願日:2004/06/07

Media Coverage 14

  1. ジフテリア菌で抗がん剤:知の拠点セミナー 「細菌毒素の研究から創薬を目指す」

    読売新聞

    2013/10

  2. 再発卵巣がんの新薬、治験開始 東大など5大学

    日本経済新聞Web版

    2013/06

  3. 東大・阪大など、卵巣抗がん剤の第2相臨床試験開始へ

    日刊工業新聞

    2013/06

  4. 卵巣がん患者に臨床試験

    読売新聞

    2013/06

  5. 再発卵巣がん 新治験

    毎日新聞

    2013/06

  6. 肺疾患モデルマウス作製

    日刊工業新聞

    2008/10

  7. 卵巣癌治療薬の医師主導治験開始

    NHK

    2007/11

  8. 卵巣癌治療薬の医師主導治験開始

    読売新聞

    2007/11

  9. 卵巣癌治療薬の医師主導治験開始

    日本経済新聞

    2007/11

  10. ジフテリア毒素変異体を用いた卵巣がん治療薬の開発について

    読売新聞

    2006/08

  11. 拡張型心筋症とHB-EGF

    NHK

    2003/09

  12. 受精の仕組み解明

    毎日新聞

    2000/01

  13. 受精は卵子たんぱく質がカギ

    読売新聞

    2000/01

  14. 卵子と精子くっつけて

    朝日新聞

    2000/01

Institutional Repository 1

Content Published in the University of Osaka Institutional Repository (OUKA)
  1. 培養細胞への定量的物質導入法とその応用

    目加田 英輔